Last reviewed · How we verify

Effect of Ketamine (Ketalar) on Intracranial Pressure

NCT00437814 NA UNKNOWN

Objectives: Ketamine is an effective, short-acting anesthetic drug, which does not decrease blood pressure. It is widely stated that Ketamine increases intracranial pressure (ICP), which prevents its use in many emergency situations, specifically in patients with traumatic brain injury (TBI) and with increased ICP. Based on previous clinical experience, we hypothesized that Ketamine decreases - rather than increases - ICP. Methods: Prospective, controlled, clinical trial. Children with ICP monitoring will receive a single Ketamine dose (1-1.5 mg/kg) either for increased ICP and/or before a potentially distressing activity. Hemodynamic variables, ICP and cerebral perfusion pressure (CPP) will be recorded 1 minute before and every minute for 10 minutes following Ketamine administration (Before/after design).

Details

Lead sponsorRambam Health Care Campus
PhaseNA
StatusUNKNOWN
Enrolment30
Start date2005-09
Completion2007-02

Conditions

Interventions

Primary outcomes

Countries

Israel